Navigation Links
Ovarian cancer in relationship with Hormone therapy

A major US study has found that women who have taken postmenopausal oestrogens for ten years or more are at substantially greater risk of fatal ovarian cancer.

The risk persists for many years after therapy is discontinued, researchers from the American Cancer Society report// in the Journal of the American Medical Association.The study followed 201,681 postmenopausal women from 1982 to 1996 and found ERT (oestrogen replacement therapy) increased the risk and this persisted for up to 29 years after women stopped using it.

Twenty two percent of the women in the study had used ERT, including 11,024 who were users at the start of the study (baseline users) and 35,236 who were former users. A total of 944 ovarian cancer deaths were recorded in the 14 year study until December 1996.

Researchers found the risk of death was approximately doubled in women who had used oestrogens for ten or more years within the 15 years prior to enrolment. Annual age-adjusted ovarian cancer death rates per 100,000 women were 64.4 for baseline users with 10 or more years of use, 38.3 for former users with 10 or more years of use, and 26.4 for never users.

Women who were using ERT at baseline had 51 percent higher death rates from ovarian cancer than those who never used ERT. Among former oestrogen users, the risk was 16 percent higher - a slight, but not significant increase. However, women who had used ERT for less than 10 years had no greater risk.

Postmenopausal oestrogen is already known to increase the risk of endometrial and breast cancer when used for a long time, but until this study, the effect of postmenopausal oestrogen use on ovarian cancer had not established.


'"/>




Page: 1

Related medicine news :

1. Exercise lowers Risk of Ovarian Cancer
2. Gene Mutation Causes Ovarian Failure
3. Ovarian Cancer Screening Questioned
4. Thawed Ovarian Transplant
5. The Benefits Of Chemotherapy For Women With Ovarian Cancer
6. Progesterone Found To Increase Ovarian Cancer Risk
7. Developmental Origins of Polycystic Ovarian Syndrome
8. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
9. Ovarian cancer risk reduced by regular exercise
10. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
11. Genetic Profile To Predict Ovarian Cancer Prognosis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ovarian cancer relationship with Hormone therapy

(Date:3/2/2015)... New York (PRWEB) March 02, 2015 ... Recovery at Recovery Unplugged™—will be delivering a plenary ... Singer/Songwriter's Perspective on the Art of Healing and ... Disorders (NCAD) and Behavioral Healthcare Executive Summit (BHES).     ... name, Mr. Supa’s songs have been recorded by ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 The ... grow at a CAGR of 6.1% to reach ... 2014. , Factors such as advantages of ... healthcare costs owing to minimally invasive surgeries and ... population are driving the global minimally invasive surgical ...
(Date:3/2/2015)... DC (PRWEB) March 02, 2015 Atlantic ... publication of AIS’s Directory of Health Plans: 2015 ... resource available on the U.S. health plan market, with ... in the United States. , Available as a ... Summary” of enrollment trends in quick-view tables and charts, ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 In light ... of anticoagulant Xarelto (rivaroxaban) tablets, Ford & ... may be helpful for future users, but may come ... injuries from taking the drug. The FDA has now ... under Adverse Reactions on Xarelto's label. The term “cytolytic ...
(Date:3/2/2015)... ProvidaStaff has announced today that it is changing ... EDU Healthcare to reflect better on the commitment ... nationwide. , “ProvidaStaff has always been a leading healthcare ... Angela M. Lewis, President of ProvidaStaff. “We continue to ... of EDU Healthcare better aligns our services to our ...
Breaking Medicine News(10 mins):Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3
... TUCSON, Ariz., July 7 The Providence Service Corporation (Nasdaq: ... in California as part of the state,s attempt to close ... we have stated previously, given that our programs in California ... Act (Proposition 63 of 2004), we do not expect to ...
... been linked to fatal overdoses , TUESDAY, July ... of fatal overdoses led U.S. health officials Tuesday ... of using pain medications containing propoxyphene, including Darvon ... of propoxyphene-containing products by adding boxed warnings that ...
... way to eat healthier without sacrificing taste just got easier. ... lovers are invited to discover the great taste of Barilla ... tries and is not completely satisfied with Barilla Whole Grain ... pasta. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090707/NY41858-a ...
... Crawford Canada,s Bill Johnstone has been named senior vice ... ; CRDB) Global Technical Services (GTS) for the Americas, ... and grow this market-leading service, the Company announced today. ... Crawford worldwide in the high-end, complex loss adjusting market. ...
... KNOXVILLE, Tenn., July 7 TeamHealth Medical Call ... its third Health Care Call Center certificate of ... accrediting organization that establishes quality standards for the ... provides comprehensive medical call center services including nurse ...
... King Pharmaceuticals, Inc. (NYSE: KG ) today announced ... Drug Application (NDA). The Company is not required by ... trials in order to provide additional safety or efficacy data ... of the resubmission plan, and in order to strengthen the ...
Cached Medicine News:Health News:Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 2Health News:FDA Mandates Tougher Warnings for Pain Pills 2Health News:Barilla(R) and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 2Health News:Barilla(R) and Celebrity Fitness Coach Bob Greene Challenge Americans to Discover the Great Taste of Whole Grain 3Health News:Bill Johnstone Named Senior Vice President of Crawford's Global Technical Services for the Americas 2Health News:TeamHealth Medical Call Center Awarded Third Consecutive URAC Health Call Center Accreditation 2Health News:King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan 2
(Date:3/2/2015)... , March 2, 2015  Delcath Systems, Inc. ... medical device company focused on oncology with an emphasis ... announces that Company management will participate in the upcoming ... March 8-11, 2015 at the Ritz Carlton Laguna Niguel ... Jennifer Simpson , PhD, MSN, CRNP, Delcath,s interim President ...
(Date:3/2/2015)... NORTH HOLLYWOOD, Calif. , March 2, 2015 ... improving the quality of life of myeloma patients ... once again declared the month of March to ... IMF first established March as Myeloma Awareness Month ... information about the disease through local community events, ...
(Date:3/2/2015)... DUBLIN , Mar. 02, 2015 Research ... announced the addition of the "Lopinavir - ... , Imagine having your own ... of a button. Used by the ... over 10 years, these searches are the benchmark ...
Breaking Medicine Technology:Delcath To Present At The 27th Annual Roth Conference 2Delcath To Present At The 27th Annual Roth Conference 3International Myeloma Foundation Declares March "Myeloma Awareness Month" 2International Myeloma Foundation Declares March "Myeloma Awareness Month" 3Global Comprehensive Lopinavir Patent Search Online Portal 2015 2
... 4, 2011 WebMD Health Corp. (Nasdaq: WBMD ... deliver a presentation at the UBS 21st Annual Global Healthcare ... ET. Investors, analysts and the general public are ... presentation over the Internet.  The broadcast can be accessed at ...
... K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a ... informed by Hologic, Inc. that the U.S. Food and ... injection).  Makena, commonly referred to as "17P," is the ... risk of preterm birth in women with a singleton ...
Cached Medicine Technology:FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 2FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 3FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 4FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 5FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 6FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 7FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 8FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 9FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 10FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 11FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth 12
... The electronic, motorized ... for all applications of ... and hard specimens in ... labs. These instruments display ...
... Leica RM2255 rotary microtome, designed for ... and resin-embedded specimens, offers a broad ... research histology laboratory. This microtome meets ... a compact, fully motorized/electronic microtome for ...
State-of-the-Art modular embedding station providing performance and ease of use to meet the needs of the most demanding user....
... system for specimen surface preparation is the ... attachment Leica SP2600. ,Ultramilling is often a ... microtomy in sample preparation. Especially with difficult ... located side by side in one specimen ...
Medicine Products: